Press release
Sexually Transmitted Diseases (STDs) Drug Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Transparency Market Research (TMR) observes, the global sexually transmitted diseases (STDs) drug market is highly competitive due to presence of several strong players. The key players are investing on the research and development activities for developing a novel drugs in order to be a part of competition. Some of the key players in the global sexually transmitted diseases drug market includes Pfizer INC, Bayer Healthcare, Hoffmann La Roche, Eli Lilly, Bristol-Myers Squibb Co., Johnson & Johnson, AbbVie, Inc., GlaxoSmithKline Plc, Gilead Sciences, and Merck & Co., Inc.TMR anticipated the global revenue of the sexually transmitted diseases (STDs) drug is estimated at US$32,826.3 mn in 2016 and expand with a CAGR of 11.2% over the forecast period from 2017 to 2025. With this pace, the market is anticipated to attain the value of US$83,041.3 mn by the end of 2025. Among various therapy classes, antibiotics segment is expected to account for the dominant share being the most frequently prescribed products in the modern medicine. Regionally, North America is accounting for the largest share in the global sexually transmitted diseases drug market.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34043
sexually transmitted diseasesGovernment Initiatives for Adoption of Drugs to Boost Growth
Prevalence of unprotected sex is a major reason behind the increasing prevalence of sexually transmitted diseases. In addition, changing lifestyle and having several causal sex partners is leading to increase prevalence of sexually transmitted diseases over the forecast period. The rising need for treatments of these diseases is boosting demand for effective drugs and treatments which is likely to boost growth of the global sexually transmitted diseases drugs market.
Buy Now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=34043<ype=S
The World Health Organization (WHO) has reported nearly 468,514 gonorrhea cases, with the rate of 145.8 cases per 100,000 people, with increase of 18.5% from 2015. Numerous governments are increasingly taking steps to reduce these cases by imposing favorable policies for adoption of sexually transmitted diseases drugs is influencing positively on the growth of the global sexually transmitted diseases drugs market. Additionally, introduction of government reforms and some improvements in healthcare facilities are fuelling growth of the global sexually transmitted diseases (STDs) drugs market.
Low Rate of Detection for Diseases due to Social Stigma to Hamper Growth
Recent technological advancements have improved the diagnosis facilities and treatments, these advancements have boosted adoption of the sexually transmitted diseases drug which is likely to fuel growth of the global sexually transmitted diseases drug market.
Request For Covid19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34043
Despite of these growth prospects, low rate of screening for diseases due to social stigma coupled with late diagnosis of the disease are crimping growth of the global sexually transmitted diseases drug market. Nevertheless, rising incidence of numerous sexually transmitted infections such as syphilis, gonorrhea, chlamydia, human papilloma virus, chancroid, herpes simplex virus, vaginitis, and trichomonas vaginalis are creating growth of the global sexually transmitted diseases drug market. Additionally, high number of pipeline drugs are expected to create lucrative opportunities for growth of the global sexually transmitted diseases drug market.
This information is comprised in the new report by TMR, titled "Sexually Transmitted Diseases (STDs) Drug Market (Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, and HIV / AIDS; Therapy Class- Antibiotics, Antiviral / Antiretrovirals, and Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025."
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
The global sexually transmitted diseases (STDs) drug market has been segmented as presented:
By Disease Type:
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV / AIDS
By Therapy Class:
Antibiotics
Antiviral / Antiretrovirals
Vaccines
By Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research - 1. https://www.prnewswire.com/news-releases/cholesterol-and-triglyceride-abnormalities-on-a-rise-driving-dyslipidemia-drugs-market-to-higher-trajectory-tmr-301024637.html
2. https://www.biospace.com/article/growing-desire-for-good-appearance-among-people-back-by-increasing-disposable-income-to-fuel-cosmetic-lasers-market/
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sexually Transmitted Diseases (STDs) Drug Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 here
News-ID: 2061073 • Views: …
More Releases from Transparency Market Research
Antibody Optimization Service Market to Reach USD 6.5 Bn by 2036, Driven by Comp …
The global antibody optimization service market is emerging as a critical pillar of modern biologics development. Once considered a supportive function within early drug discovery, antibody optimization has evolved into an essential, integrated component of therapeutic antibody development. Increasing biological complexity, regulatory scrutiny, and the race to accelerate Investigational New Drug (IND) submissions are driving biopharmaceutical companies to invest heavily in specialized optimization services.
According to the latest market analysis, the…
Lithium-Ion Battery Market Outlook 2036: EV Boom, 10.1% CAGR, and Revenue Surge …
The global lithium-ion battery market was valued at US$ 32.1 billion in 2025 and is projected to reach US$ 92.9 billion by 2036, expanding at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2036.
This nearly threefold expansion over the forecast period reflects the accelerating electrification of transportation, rapid renewable energy integration, and increasing demand for portable and industrial power solutions. The market's strong double-digit growth trajectory highlights…
Athletic Footwear Market to Reach USD 215.3 Mn by 2036 - By Product Type / Mater …
The global athletic footwear market is witnessing steady expansion, supported by increasing consumer focus on fitness, comfort-driven fashion trends, and technological advancements in footwear design. The market was valued at US$ 132.3 Mn in 2025 and is projected to reach US$ 215.3 Mn by 2036, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period from 2026 to 2036.
Access key findings and insights from our Report in…
Ceramic Sanitary Ware Market to Reach USD 73.7 Bn by 2036 at 6.8% CAGR | Transpa …
The global ceramic sanitary ware market is witnessing robust expansion, supported by rapid urbanization, rising hygiene awareness, and increasing construction activities worldwide. Ceramic sanitary ware refers to bathroom and washroom fixtures manufactured using materials such as vitreous china, porcelain, and stoneware. These products include toilets, wash basins, urinals, bidets, bathtubs, and related accessories used across residential, commercial, and institutional settings.
According to the latest market analysis, the global ceramic sanitary ware…
More Releases for STDs
Diagnostic Testing of STDs Market Predicted Double-Digit Growth Rate by 2028
Diagnostic Testing of STDs Market Research study which offers perceptivity of in- depth delving on major and current request size along with the expected future prospects of the request and arising trends in the request. The Diagnostic Testing of STDs Market report provides crucial information about the request, including Opinions from diligence experts, and accordingly the recent progressions and developments of the Diagnostic Testing of STDs Market.
The report contains documentary…
Influence of Covid-19 on Sexually Transmitted Diseases (STDs) Drug Market
Transparency Market Research (TMR) observes, the global sexually transmitted diseases (STDs) drug market is highly competitive due to presence of several strong players. The key players are investing on the research and development activities for developing a novel drugs in order to be a part of competition. Some of the key players in the global sexually transmitted diseases drug market includes Pfizer INC, Bayer Healthcare, Hoffmann La Roche, Eli Lilly,…
STDs Diagnosis Market : Industry Growth, Size, Manufacturers, Sales and Demand
ReportsnReports recently announces a latest research report titled “Global STDs Diagnosis Market 2018” which highlights the STDs Diagnosis Market size, comprehensive STDs Diagnosis Industry dynamics and high-tech updates of global STDs Diagnosis Market with respect to STDs Diagnosis Industry opportunities, threats, challenges, constraints, cost structure and current trends in the STDs Diagnosis Industry. This independent 116 Page report based on analysis over 6 Major Key Players guarantees you will remain…
Sexually Transmitted Diseases (STDs) Treatment Market Outlook and Opportunity An …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin…
Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018 …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin…
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of…
